Psoriasis is classified as a systemic inflammatory disease, not simply a skin condition. Its impact extends well beyond the skin, with substantial evidence linking psoriasis to depression, anxiety, social withdrawal, and reduced quality of life.
The Numbers
- Patients with psoriasis have a 39% higher risk of depression than the general population
- Up to 30% of psoriasis patients develop psoriatic arthritis
- People with severe psoriasis have significantly elevated rates of cardiovascular disease, metabolic syndrome, and inflammatory bowel disease
Why Psoriasis Affects Mental Health
The visible nature of psoriasis, plaques often appear on the face, scalp, hands, and other exposed areas, creates a constant risk of stigma and social judgment. Many patients report avoiding swimming, intimate relationships, or certain careers because of their condition.
Beyond the social impact, the inflammatory biology of psoriasis directly affects the brain. Pro-inflammatory cytokines cross the blood-brain barrier and influence neurotransmitter pathways associated with mood.
The Role of Effective Treatment
Studies consistently show that achieving significant skin clearance, particularly PASI 75 or better, produces meaningful improvements in depression and anxiety scores. Treating the skin effectively also treats the mental health component of the disease.
Addressing Both Together
Patients with psoriasis should discuss psychological impact with their physician. Mental health support, whether counseling, mindfulness, or medication, is a legitimate and important component of comprehensive psoriasis care.
Clinical Trials: An Option Worth Considering
If current treatment is not achieving adequate clearance, a clinical trial may offer access to newer treatments. View our psoriasis study at NuLine in Oakland Park.